世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multiple Sclerosis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3955 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ベータインターフェロン、コルチコステロイド、モノクローナル抗体、抗腫瘍剤、その他）、用途別市場規模（病院薬局、小売薬局、eコマース）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・多発性硬化症治療の市場動向 ・企業の競争状況、市場シェア ・多発性硬化症治療の種類別市場規模（ベータインターフェロン、コルチコステロイド、モノクローナル抗体、抗腫瘍剤、その他） ・多発性硬化症治療の用途別市場規模（病院薬局、小売薬局、eコマース） ・多発性硬化症治療の北米市場規模2016-2027（アメリカ、カナダ） ・多発性硬化症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・多発性硬化症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・多発性硬化症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・多発性硬化症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Teva Pharmaceuticals、Sanofi Genzyme、Bayer、Pfizer、Biogen Idec、Merck、AbbVie） ・結論

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

Market Analysis and Insights: Global Multiple Sclerosis Therapeutics Market
The global Multiple Sclerosis Therapeutics market size is projected to reach US$ 19600 million by 2026, from US$ 17030 million in 2019, at a CAGR of 2.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiple Sclerosis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiple Sclerosis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiple Sclerosis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiple Sclerosis Therapeutics market.

Global Multiple Sclerosis Therapeutics Scope and Market Size
Multiple Sclerosis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Sclerosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Beta Interferon
Corticosteroids
Monoclonal Antibodies
Antineoplastic Agents
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
e-Commerce

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Teva Pharmaceuticals
Sanofi Genzyme
Bayer
Pfizer
Biogen Idec
Merck
AbbVie

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Sclerosis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Beta Interferon
1.2.3 Corticosteroids
1.2.4 Monoclonal Antibodies
1.2.5 Antineoplastic Agents
1.2.6 Others
1.3 Market by Application
1.3.1 Global Multiple Sclerosis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 e-Commerce
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multiple Sclerosis Therapeutics Market Perspective (2016-2027)
2.2 Multiple Sclerosis Therapeutics Growth Trends by Regions
2.2.1 Multiple Sclerosis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multiple Sclerosis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Multiple Sclerosis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Multiple Sclerosis Therapeutics Industry Dynamic
2.3.1 Multiple Sclerosis Therapeutics Market Trends
2.3.2 Multiple Sclerosis Therapeutics Market Drivers
2.3.3 Multiple Sclerosis Therapeutics Market Challenges
2.3.4 Multiple Sclerosis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multiple Sclerosis Therapeutics Players by Revenue
3.1.1 Global Top Multiple Sclerosis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Multiple Sclerosis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Multiple Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multiple Sclerosis Therapeutics Revenue
3.4 Global Multiple Sclerosis Therapeutics Market Concentration Ratio
3.4.1 Global Multiple Sclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Therapeutics Revenue in 2020
3.5 Multiple Sclerosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Multiple Sclerosis Therapeutics Product Solution and Service
3.7 Date of Enter into Multiple Sclerosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Sclerosis Therapeutics Breakdown Data by Type
4.1 Global Multiple Sclerosis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Multiple Sclerosis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Multiple Sclerosis Therapeutics Breakdown Data by Application
5.1 Global Multiple Sclerosis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Multiple Sclerosis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multiple Sclerosis Therapeutics Market Size (2016-2027)
6.2 North America Multiple Sclerosis Therapeutics Market Size by Type
6.2.1 North America Multiple Sclerosis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Multiple Sclerosis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Multiple Sclerosis Therapeutics Market Size by Type (2016-2027)
6.3 North America Multiple Sclerosis Therapeutics Market Size by Application
6.3.1 North America Multiple Sclerosis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Multiple Sclerosis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Multiple Sclerosis Therapeutics Market Size by Application (2016-2027)
6.4 North America Multiple Sclerosis Therapeutics Market Size by Country
6.4.1 North America Multiple Sclerosis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Multiple Sclerosis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Multiple Sclerosis Therapeutics Market Size (2016-2027)
7.2 Europe Multiple Sclerosis Therapeutics Market Size by Type
7.2.1 Europe Multiple Sclerosis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Multiple Sclerosis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Multiple Sclerosis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Multiple Sclerosis Therapeutics Market Size by Application
7.3.1 Europe Multiple Sclerosis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Multiple Sclerosis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Multiple Sclerosis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Multiple Sclerosis Therapeutics Market Size by Country
7.4.1 Europe Multiple Sclerosis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Multiple Sclerosis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multiple Sclerosis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multiple Sclerosis Therapeutics Market Size (2016-2027)
9.2 Latin America Multiple Sclerosis Therapeutics Market Size by Type
9.2.1 Latin America Multiple Sclerosis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Multiple Sclerosis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Multiple Sclerosis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Multiple Sclerosis Therapeutics Market Size by Application
9.3.1 Latin America Multiple Sclerosis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Multiple Sclerosis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Multiple Sclerosis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Multiple Sclerosis Therapeutics Market Size by Country
9.4.1 Latin America Multiple Sclerosis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Multiple Sclerosis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multiple Sclerosis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Multiple Sclerosis Therapeutics Introduction
11.1.4 Novartis Revenue in Multiple Sclerosis Therapeutics Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Details
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Introduction
11.2.4 Teva Pharmaceuticals Revenue in Multiple Sclerosis Therapeutics Business (2016-2021)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Sanofi Genzyme
11.3.1 Sanofi Genzyme Company Details
11.3.2 Sanofi Genzyme Business Overview
11.3.3 Sanofi Genzyme Multiple Sclerosis Therapeutics Introduction
11.3.4 Sanofi Genzyme Revenue in Multiple Sclerosis Therapeutics Business (2016-2021)
11.3.5 Sanofi Genzyme Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Multiple Sclerosis Therapeutics Introduction
11.4.4 Bayer Revenue in Multiple Sclerosis Therapeutics Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Multiple Sclerosis Therapeutics Introduction
11.5.4 Pfizer Revenue in Multiple Sclerosis Therapeutics Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Biogen Idec
11.6.1 Biogen Idec Company Details
11.6.2 Biogen Idec Business Overview
11.6.3 Biogen Idec Multiple Sclerosis Therapeutics Introduction
11.6.4 Biogen Idec Revenue in Multiple Sclerosis Therapeutics Business (2016-2021)
11.6.5 Biogen Idec Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Multiple Sclerosis Therapeutics Introduction
11.7.4 Merck Revenue in Multiple Sclerosis Therapeutics Business (2016-2021)
11.7.5 Merck Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Multiple Sclerosis Therapeutics Introduction
11.8.4 AbbVie Revenue in Multiple Sclerosis Therapeutics Business (2016-2021)
11.8.5 AbbVie Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multiple Sclerosis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Beta Interferon
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Antineoplastic Agents
Table 6. Key Players of Others
Table 7. Global Multiple Sclerosis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Multiple Sclerosis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Multiple Sclerosis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Multiple Sclerosis Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Multiple Sclerosis Therapeutics Market Share by Regions (2022-2027)
Table 13. Multiple Sclerosis Therapeutics Market Trends
Table 14. Multiple Sclerosis Therapeutics Market Drivers
Table 15. Multiple Sclerosis Therapeutics Market Challenges
Table 16. Multiple Sclerosis Therapeutics Market Restraints
Table 17. Global Multiple Sclerosis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Multiple Sclerosis Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Multiple Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Therapeutics as of 2020)
Table 20. Ranking of Global Top Multiple Sclerosis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Multiple Sclerosis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiple Sclerosis Therapeutics Product Solution and Service
Table 24. Date of Enter into Multiple Sclerosis Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Multiple Sclerosis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Multiple Sclerosis Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Multiple Sclerosis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Multiple Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Multiple Sclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Multiple Sclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Multiple Sclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Multiple Sclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Multiple Sclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Multiple Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Multiple Sclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Multiple Sclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Multiple Sclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Multiple Sclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Multiple Sclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Multiple Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Multiple Sclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Multiple Sclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Multiple Sclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Multiple Sclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Multiple Sclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis Multiple Sclerosis Therapeutics Product
Table 67. Novartis Revenue in Multiple Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Teva Pharmaceuticals Company Details
Table 70. Teva Pharmaceuticals Business Overview
Table 71. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product
Table 72. Teva Pharmaceuticals Revenue in Multiple Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Teva Pharmaceuticals Recent Development
Table 74. Sanofi Genzyme Company Details
Table 75. Sanofi Genzyme Business Overview
Table 76. Sanofi Genzyme Multiple Sclerosis Therapeutics Product
Table 77. Sanofi Genzyme Revenue in Multiple Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Sanofi Genzyme Recent Development
Table 79. Bayer Company Details
Table 80. Bayer Business Overview
Table 81. Bayer Multiple Sclerosis Therapeutics Product
Table 82. Bayer Revenue in Multiple Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Bayer Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Multiple Sclerosis Therapeutics Product
Table 87. Pfizer Revenue in Multiple Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Biogen Idec Company Details
Table 90. Biogen Idec Business Overview
Table 91. Biogen Idec Multiple Sclerosis Therapeutics Product
Table 92. Biogen Idec Revenue in Multiple Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Biogen Idec Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Multiple Sclerosis Therapeutics Product
Table 97. Merck Revenue in Multiple Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Merck Recent Development
Table 99. AbbVie Company Details
Table 100. AbbVie Business Overview
Table 101. AbbVie Revenue in Multiple Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 102. AbbVie Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Sclerosis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Beta Interferon Features
Figure 3. Corticosteroids Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Antineoplastic Agents Features
Figure 6. Others Features
Figure 7. Global Multiple Sclerosis Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. e-Commerce Case Studies
Figure 11. Multiple Sclerosis Therapeutics Report Years Considered
Figure 12. Global Multiple Sclerosis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Multiple Sclerosis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Multiple Sclerosis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Multiple Sclerosis Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Multiple Sclerosis Therapeutics Market Share by Players in 2020
Figure 17. Global Top Multiple Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Multiple Sclerosis Therapeutics Revenue in 2020
Figure 19. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Multiple Sclerosis Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Multiple Sclerosis Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Multiple Sclerosis Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Multiple Sclerosis Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Multiple Sclerosis Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Multiple Sclerosis Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Region (2016-2027)
Figure 41. China Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Multiple Sclerosis Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Multiple Sclerosis Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Multiple Sclerosis Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Multiple Sclerosis Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Multiple Sclerosis Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Multiple Sclerosis Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Multiple Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Novartis Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2016-2021)
Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2016-2021)
Figure 62. Sanofi Genzyme Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2016-2021)
Figure 65. Biogen Idec Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2016-2021)
Figure 67. AbbVie Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---